Typical follow-up schedules include an initial follow-up at 4 weeks after starting to assess initial tolerance and response, then follow-up at each dose increase (when moving from 0.25mg to 0.5mg to 1mg), and quarterly appointments once youre on a stable maintenance dose
IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
The medication slows down the movement of food through your gut, Parrella said, which makes the above gastrointestinal symptoms common, in addition to things such as acid reflux, heartburn and burping
Furthermore, EGT deficiency in A
Because retatrutide is administered as a once-weekly subcutaneous injection, its long pharmacokinetic half-life estimated at approximately six days in the Phase 2 trial data means that plasma concentrations remain relatively stable throughout the week